NCT00571727View on ClinicalTrials.gov

Long-Term Treatment With rhIGF-1 in GHIS

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

May 20, 1991

Primary Completion Date

December 15, 2011

Study Completion Date

December 15, 2011

Conditions
Growth Hormone Insensitivity Syndrome
Interventions
DRUG

mecasermin

injections BID of rhIGF-1, mecasermin

Trial Locations (1)

94005

Ipsen, Brisbane

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
collaborator

University of Oklahoma

OTHER

lead

Ipsen

INDUSTRY